We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topics
- COVID-19 (127)
- COVID-19 vaccines (80)
- Advertising (77)
- Prescription medicines (33)
- Regulatory compliance (19)
- Alert/Advisory (15)
- Medicines safety (15)
- Safety (7)
- In Vitro Diagnostic medical devices (IVDs) (6)
- Manufacturing (6)
- Disinfectants/Sterilants (5)
- Labelling and packaging (3)
- Over the counter (OTC) medicines (3)
- Australian Register of Therapeutic Goods (ARTG) (2)
- Shortages (2)
- Cosmetics (1)
- Import and export (1)
- Listed medicines (1)
- Medicinal cannabis hub (1)
- Non-prescription medicines (1)
- Scheduling (national classification system) (1)
Results for
"[search-keyword]"
Collection content
308 result(s) found, displaying 301 to 308
-
Media releasesThe TGA will take action in relation to the illegal advertising of therapeutic goods, including those that make false and misleading claims about preventing or curing COVID-19
-
Safety alertsOnly certain types of specialists will be able to prescribe hydroxychloroquine to new patients
-
Scheduling decisions (final)Amendments in relation to hydroxychloroquine and salbutamol
-
-
Media releasesDue to changes in travel restrictions, all overseas GMP inspections and QMS audits have now been suspended until further notice
-
Media releasesCommunity pharmacists to enforce new limits on dispensing and sales of prescription and over-the-counter medicines
-
-
Media releasesStockpiling medicines may disrupt access to vital medicines by patients and pharmacies